Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SeaStar Medical Holding (ICUCW) EBITDA Margin (2023 - 2025)

SeaStar Medical Holding's EBITDA Margin history spans 3 years, with the latest figure at 1711.92% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 882684.0% year-over-year to 1711.92%; the TTM value through Dec 2025 reached 212.42%, up 1300388.0%, while the annual FY2025 figure was 212.58%, 1300371.0% up from the prior year.
  • EBITDA Margin reached 1711.92% in Q4 2025 per ICUCW's latest filing, up from 1955.74% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 1711.92% in Q4 2025 to a low of 7114.93% in Q4 2024.
  • Average EBITDA Margin over 3 years is 1626.38%, with a median of 911.98% recorded in 2025.
  • The largest YoY upside for EBITDA Margin was 882684bps in 2025 against a maximum downside of 459720bps in 2025.
  • A 3-year view of EBITDA Margin shows it stood at 1666.67% in 2023, then crashed by -527bps to 7114.93% in 2024, then skyrocketed by 124bps to 1711.92% in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's EBITDA Margin are 1711.92% (Q4 2025), 1955.74% (Q3 2025), and 519.53% (Q2 2025).